FDA Issues Warnings Regarding Xeljanz (tofacitinib)
On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of
Learn MoreDangerous Drugs
Philadelphia Judge Takes Unique Approach To Xarelto Trial Selection Process
Philadelphia Court of Common Pleas Judge Arnold New is opting for the bellwether selection system in the Xarelto
Learn More
FDA Issues Warnings About ‘Uncontrollable Urges’ Associated With Abilify
The U.S. Food and Drug Administration (FDA) has added warnings about “uncontrollable urges” to the drug label and
Learn More
CSS Files Lawsuits on Behalf of Patients Who Developed SJS
Childers, Schlueter & Smith, LLC has recently filed suit for cases in which patients developed Stevens-Johnson Syndrome (SJS)
Learn MoreXarelto Case Count Continues to Rise
More than 770 Xarelto cases have now been filed in Philadelphia’s Complex Litigation Center, joining another 2,800 that
Learn More